Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach
优化镰状细胞性贫血儿童预防服务接受的机会:混合方法
基本信息
- 批准号:10693833
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The proposed project will provide critical information to inform the development and implementation of
interventions to improve the receipt of preventive services among children with sickle cell anemia. National
guidelines strongly recommend that children with sickle cell anemia receive routine screenings and be offered
preventive medications to reduce the risk of serious complications including infections, strokes, and pain
crises. Although these complications are associated with increased health services utilization and cost, and
reduced quality of life, only 40% of children receive routine screenings and less than 20% receive preventive
medications. Significantly, the mechanisms driving quality gaps in the receipt of preventive services are
unknown, limiting our ability to develop and implement impactful interventions. The overall objective of this
study is to shed light on these mechanisms and identify opportunities to optimize receipt of preventive
services among children with sickle cell anemia, thus reducing disease burden and improving quality
of life. The proposed study directly impacts the following AHRQ priority populations: children, racial and ethnic
minorities, low-income patients, and those with special healthcare needs. As such, it aligns with AHRQ’s
mission to improve efficiency and quality of health care delivery for vulnerable populations.
Using a mixed methods approach, we will (1) identify critical targets within the healthcare delivery
system, as well as key subgroups of the population, through which intervention can improve the receipt of
preventive services for children with sickle cell anemia; (2) identify barriers to and facilitators of receipt of
preventive services, and (3) integrate the quantitative findings of patterns of care and adherence deficiencies
with the qualitative findings of barriers and facilitators to preventive services to identify intervention targets and
strategies that are most likely to improve receipt of preventive services. The mixed methods approach includes
analyzing data from three large complementary, nationally representative datasets, combined with primary
qualitative data collection. The datasets provide a novel opportunity to provide a population-based perspective
on the care of children with sickle cell anemia, as well as national data on prescribing practices. Quantitative
methods, including machine learning and time-dependent survival analysis, will enable us to characterize
patterns of care associated with receipt of preventive services, as well variation in adherence across providers,
patients, caregivers, and insurance type. Qualitative, key informant interviews with provider teams, caregivers,
and patients will identify potential barriers to and facilitators of adherence to each preventive service, as well as
opportunities for intervention. Finally, the visual integration of the quantitative analysis with the qualitative
findings through a joint display will provide essential information regarding which intervention targets and
strategies are most likely to improve receipt of preventive services and ultimately reduce morbidity among
children with sickle cell anemia.
项目摘要
拟议项目将提供重要信息,为制定和实施
采取干预措施,改善镰状细胞贫血儿童接受预防服务的情况。国家
指南强烈建议患有镰状细胞性贫血的儿童接受常规筛查,
预防性药物,以减少严重并发症的风险,包括感染,中风和疼痛
危机尽管这些并发症与卫生服务利用率和成本增加有关,
生活质量下降,只有40%的儿童接受常规筛查,不到20%的儿童接受预防性筛查。
药物治疗值得注意的是,造成预防服务质量差距的机制是
未知,限制了我们制定和实施有效干预措施的能力。本报告的总体目标
研究的目的是阐明这些机制,并确定优化预防性治疗的机会。
为患有镰状细胞性贫血的儿童提供服务,从而减少疾病负担并提高质量
生命拟议的研究直接影响以下AHRQ优先人群:儿童、种族和民族
少数民族、低收入患者和有特殊医疗需求的患者。因此,它与AHRQ的
使命是提高向弱势群体提供保健服务的效率和质量。
使用混合方法,我们将(1)确定医疗保健服务中的关键目标
系统以及人口的关键亚群,通过这些干预措施可以改善对
为患有镰状细胞性贫血的儿童提供预防服务;(2)确定接受
预防性服务,(3)整合护理模式和依从性缺陷的定量结果
根据预防服务的障碍和促进因素的定性结果,确定干预目标,
最有可能改善预防服务接受情况的战略。混合方法包括
分析来自三个大型互补的、具有全国代表性的数据集的数据,
定性数据收集。这些数据集提供了一个新的机会,以提供基于人口的视角
关于镰状细胞性贫血儿童护理的国家数据以及关于处方做法的国家数据。定量
包括机器学习和时间依赖生存分析在内的方法将使我们能够描述
与接受预防服务相关的护理模式,以及提供者之间依从性的差异,
患者、护理人员和保险类型。与提供者团队、护理人员、
和患者将确定潜在的障碍和促进遵守每一项预防服务,以及
干预的机会。最后,定量分析与定性分析的可视化整合
通过联合展示的调查结果将提供有关哪些干预目标和
这些战略最有可能改善预防服务的接受情况,并最终降低
患有镰状细胞性贫血的儿童。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Leasure Reeves其他文献
Sarah Leasure Reeves的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Leasure Reeves', 18)}}的其他基金
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach
优化镰状细胞性贫血儿童预防服务接受的机会:混合方法
- 批准号:
10469404 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Opportunities to optimize the receipt of preventive services among children with sickle cell anemia: A Mixed Methods Approach
优化镰状细胞性贫血儿童预防服务接受的机会:混合方法
- 批准号:
10294429 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease
寻找改善镰状细胞病儿童羟基脲治疗起始和依从性的机会
- 批准号:
9088921 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease
寻找改善镰状细胞病儿童羟基脲治疗起始和依从性的机会
- 批准号:
9335437 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
Applying a Program Science approach for strengthening partnerships and advancing embedded research to optimize public health programming for HIV and sexually transmitted and blood-borne infections among criminalized populations in the Global South
应用计划科学方法来加强伙伴关系并推进嵌入式研究,以优化南半球犯罪人群中针对艾滋病毒、性传播和血源性感染的公共卫生规划
- 批准号:
502554 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
SBIR Phase II: An Integrated Biomedical Platform and Custom Algorithm to Optimize Feeding Protocols for Preterm Infants
SBIR 第二阶段:用于优化早产儿喂养方案的综合生物医学平台和定制算法
- 批准号:
2335207 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
Cooperative Agreement
Identifying user preferences to optimize HIV/Sexually Transmitted infections test among international migrants and tourists in Japan: A Discrete Choice Experiment
确定用户偏好以优化日本国际移民和游客的艾滋病毒/性传播感染测试:离散选择实验
- 批准号:
24K20238 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Using precision fermentation to optimize biofertilizer preparation
利用精准发酵优化生物肥料制备
- 批准号:
10075820 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Grant for R&D
Using an Artificial Intelligence Quality Indicator to optimize and evaluate delirium prevention efforts in hospitals
使用人工智能质量指标优化和评估医院谵妄预防工作
- 批准号:
484346 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Operating Grants
Research on the Structural Reinforcement to Optimize the Axial Tension of Rigid Riser in Water Depth Below 4,000m
4000m以下水深刚性立管轴拉力优化的结构加固研究
- 批准号:
23K04265 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase II: A Blockchain Ecosystem for Encrypting Real World Data and Developing Artificial Intelligence to Optimize Pharmacy Prior Authorization
SBIR 第二阶段:用于加密现实世界数据和开发人工智能以优化药房预授权的区块链生态系统
- 批准号:
2200163 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Cooperative Agreement
Mobile Health and Oral Testing to Optimize Tuberculosis Contact Tracing in Colombia
移动健康和口腔测试可优化哥伦比亚的结核病接触者追踪
- 批准号:
10667885 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
使用 IL-1R1 及其配体优化 T 细胞对癌症的免疫反应
- 批准号:
10801033 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Implementation of an impact assessment tool to optimize responsible stewardship of genomic data in the cloud
实施影响评估工具以优化云中基因组数据的负责任管理
- 批准号:
10721762 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:














{{item.name}}会员




